Hatton National Bank PLC Pharmaceutical Import Profile — Sri Lanka (DGFT 2022–2026)

Name: Hatton National Bank PLC Pharmaceutical Import Records from India — 4 Products, $494.5K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus

Suresh Sormare

Explore

Hatton National Bank PLC — Pharmaceutical Importer Profile (2026) | 4 Products, $494.5K Trade | TransData Nexus

Hatton National Bank PLC

Pharmaceutical Importer · Sri Lanka · Immunosuppressants Focus · $494.5K Total Trade · DGFT Verified

Hatton National Bank PLC is a pharmaceutical importer based in Sri Lanka with a total trade value of $494.5K across 4 products in 4 therapeutic categories. Based on 20 verified import shipments from Indian Customs (DGFT) records, the company actively imports across multiple product segments. Hatton National Bank PLC sources from 16 verified Indian suppliers, with Torrent Pharmaceuticals Limited accounting for 80.6% of imports.

Hatton National Bank PLC — Import Portfolio & Supplier Network

Hatton National Bank PLC import network — 4 products from Indian suppliers. Source: Indian Customs (DGFT).

Who Are the Verified Indian Suppliers to Hatton National Bank PLC?

Customs-verified supplier relationships from Indian DGFT records

Supplier	Value	Shipments	Share
Torrent Pharmaceuticals Limited	$6.1M	293	80.6%
Sun Pharmaceutical Industries Limited	$452.9K	17	6.0%
Gufic Biosciences Limited

What Formulations Does Hatton National Bank PLC Import?

Formulation	Value	Ships
Torleva 500 tablet (levetiracetam 500MG)(nos = 6x10 TAB)	$150.0K	3
Valparin 200 alkalets tablet (sodium valproate 200 MG) (nos = 10x10 TAB.)	$123.9K	4
Nexpro 20MG tablet (esomeprazole magnesium 20MG) (nos = 10x10 TAB	$114.2K	4
Telday 80 tablet (telmisartan 80 MG) (nos = 10x10 tablets)	$110.6K	3
Ticplat 200 INJ (teicoplanin for INJ	$110.5K	3
Prolomet xl TAB 50MG act.qty. 10128	$100.0K	2
Nexpro 40 tablet (esomeprazole magnesium40mg) (nos = 10x10 tablets)	$100.0K	2
Azukon mr 30 tablet (gliclazide 30MG )(nos = 10x10 TAB.)	$100.0K	2
Dibeta sr tablet (metformin hydrochloride extended release tablets USP 500 MG) (nos = 3x10 tablets)	$84.6K	5
Lefra 10 tablet (leflunomide 10 MG) (nos= 30x10 TAB)	$84.0K	2
Nexpro 40 tablet (esomeprazole	$75.9K	2
Nexpro 20MG tablet( esomeprazole magnesium tablets 20MG ) (nos=10x10 TAB)	$72.1K	2
Valparin 200 alkalets tablet (sodium	$71.0K	2
Mosid mt 5 tablet(mosapride citrate 5MG)nos=10x10	$66.2K	3
Pharmaceuticals- cefakind-500 tabs -	$65.3K	3

Hatton National Bank PLC imports 315 distinct pharmaceutical formulations. Showing top 15 by value. For full formulation-level data, contact TransData Nexus.

Import Portfolio — Top 4 by Import Value

#	Product	Category	Value	Ships	Share	Rk
1	Leflunomide	Immunosuppressants	$250.0K	5	1.7%	9
2	Teicoplanin	Advanced Antibiotics	$110.5K	3	1.8%	12
3	Empagliflozin	Diabetes & Endocrine	$82.7K	8	1.2%	16
4	Captopril	Cardiovascular	$51.2K	4	0.4%	15

Hatton National Bank PLC imports 4 pharmaceutical products across 4 categories into Sri Lanka totaling $494.5K.

Hatton National Bank PLC — Corporate Profile & Information

Company type, headquarters, distribution network, and industry role

1Company Overview

Hatton National Bank PLC (HNB) is a prominent private sector bank in Sri Lanka, established in 1888 and headquartered in Colombo. Over the years, HNB has expanded its operations to include 255 branches and 825 ATMs across the country, offering a comprehensive range of banking services to individuals, businesses, and organizations.

While HNB's primary focus is on financial services, it also engages in various import activities, including the procurement of pharmaceutical products. In 2023, the bank reported pharmaceutical imports amounting to LKR 317 million, indicating its involvement in the healthcare sector.

2Distribution Network

HNB's distribution network is primarily centered around its extensive banking infrastructure, with 255 branches and 825 ATMs nationwide. However, specific details regarding warehouse locations, logistics capabilities, and geographic coverage for pharmaceutical imports are not publicly disclosed. Given the bank's significant presence in Sri Lanka, it is likely that its logistics operations are well-integrated to support its import activities.

3Industry Role

In the pharmaceutical supply chain, HNB functions as an importer and distributor of finished pharmaceutical formulations. The bank's import activities are part of its broader engagement in the healthcare sector, complementing its core banking services. While not a primary wholesaler, HNB's role in importing and distributing pharmaceutical products contributes to the availability of essential medications in the Sri Lankan market.

TransData Nexus Research · Company registries, industry databasesMar 2026

Supplier Relationship Intelligence — Hatton National Bank PLC

Sourcing concentration, supply chain resilience, and strategic implications

1Sourcing Concentration Analysis

HNB's pharmaceutical imports from India are concentrated among a few suppliers, with the top five products accounting for 100% of the import value. This indicates a high level of dependency on these specific products and suppliers. The substantial import value of Leflunomide ($250K) and Teicoplanin ($111K) suggests that these products are critical to HNB's pharmaceutical portfolio. The concentration may pose risks related to supply chain disruptions or price fluctuations.

2Supply Chain Resilience

HNB's reliance on a limited number of suppliers for its pharmaceutical imports from India could impact the resilience of its supply chain. The bank's import data indicates a focus on specific formulations, which may limit its ability to diversify sourcing. Additionally, the concentration of shipments from a few suppliers suggests potential vulnerabilities to supply chain disruptions. Ensuring the regulatory compliance of key suppliers and exploring alternative sourcing options could enhance supply chain resilience.

3Strategic Implications

Importing Pharmaceuticals into Sri Lanka — Regulatory Framework

Regulatory authority, GMP requirements, import licensing for Sri Lanka

1Regulatory Authority & Framework

The National Medicines Regulatory Authority (NMRA) is the primary drug regulatory body in Sri Lanka, responsible for ensuring the safety, efficacy, and quality of pharmaceuticals. Key legislation governing pharmaceutical imports includes the National Medicines Regulatory Authority Act No. 5 of 2015, which outlines the procedures for registration, importation, and distribution of medicinal products. The marketing authorization pathway for Indian generics involves obtaining registration from the NMRA, which assesses the quality, safety, and efficacy of the products before granting approval.

2Import Licensing & GMP

Import licensing requirements for pharmaceutical products in Sri Lanka are stringent, necessitating compliance with the NMRA's regulations. Manufacturers must provide Good Manufacturing Practice (GMP) certificates recognized by the NMRA, such as those from the World Health Organization (WHO) or the Pharmaceutical Inspection Co-operation Scheme (PIC/S). Importers like HNB must ensure that their suppliers meet these GMP standards to facilitate the importation process.

3Quality & Labeling

Hatton National Bank PLC — Procurement Pattern Analysis

Product strategy, sourcing profile, and market positioning

1Product Strategy

HNB's focus on importing immunosuppressants, advanced antibiotics, and diabetes & endocrine medications aligns with the growing healthcare needs in Sri Lanka. The substantial import value of Leflunomide and Teicoplanin indicates a strategic emphasis on critical therapeutic areas. Market demand for these products is driven by the prevalence of autoimmune diseases, infections, and diabetes in the population.

2Sourcing Profile

HNB's sourcing strategy is centered on importing generic drugs from India, particularly in the therapeutic categories of immunosuppressants, advanced antibiotics, and diabetes & endocrine medications. The bank's import data reveals a preference for specific formulations, suggesting a targeted approach to procurement. India's established pharmaceutical manufacturing capabilities and competitive pricing make it a preferred sourcing destination for HNB.

3Market Positioning

Based on its product mix, HNB serves the hospital and wholesale distribution segments of the Sri Lankan pharmaceutical market. The importation of specialized medications positions the bank as a key supplier to healthcare institutions and distributors, contributing to the availability of essential treatments in the country.

Seller's Guide — How to Become a Supplier to Hatton National Bank PLC

Opportunity assessment, qualifications, and practical approach strategy

1Opportunity Assessment

There is a realistic opportunity for new Indian suppliers to engage with HNB, particularly those offering high-quality generic drugs in the therapeutic areas of immunosuppressants, advanced antibiotics, and diabetes & endocrine medications. Gaps in HNB's current sourcing include a limited range of suppliers and formulations, presenting an opportunity for diversification and strengthening the supply chain.

2Requirements & Qualifications

Indian exporters seeking to supply HNB must ensure that their products are registered with the NMRA and comply with Sri Lankan import regulations. Suppliers must provide GMP certificates recognized by the NMRA, such as those from WHO or PIC/S. Additionally, adherence to quality standards, including batch testing and stability requirements, is essential.

3How to Approach

To build a relationship with HNB, Indian exporters should initiate contact with the bank's trade services department, providing detailed product information and demonstrating compliance with regulatory requirements. Participating in tenders and responding to requests for proposals can enhance visibility. A clear regulatory filing strategy, including obtaining necessary registrations and certifications, is crucial. Timelines for approval may vary, so proactive communication and adherence to regulatory processes are recommended.

Frequently Asked Questions — Hatton National Bank PLC

What products does Hatton National Bank PLC import from India?

Hatton National Bank PLC imports 4 pharmaceutical products across 4 categories. Top imports: Leflunomide ($250.0K), Teicoplanin ($110.5K), Empagliflozin ($82.7K), Captopril ($51.2K).

Who supplies pharmaceuticals to Hatton National Bank PLC from India?

Hatton National Bank PLC sources from 16 verified Indian suppliers. The primary supplier is Torrent Pharmaceuticals Limited (80.6% of imports, $6.1M).

What is Hatton National Bank PLC's total pharmaceutical import value?

Hatton National Bank PLC's total pharmaceutical import value from India is $494.5K, based on 20 verified shipments in Indian Customs (DGFT) data.

What therapeutic categories does Hatton National Bank PLC focus on?

Hatton National Bank PLC imports across 4 categories. The largest: Immunosuppressants (50.6%), Advanced Antibiotics (22.4%), Diabetes & Endocrine (16.7%).

Get Full Hatton National Bank PLC Import Intelligence

Access shipment-level details, supplier connections, pricing data, and competitive analysis. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.

Contact for Data Access Request Live Demo

Official References & Regulatory Resources

Verify import regulations and drug registration requirements with the agencies above.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Data Source & Methodology

Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Profile aggregates 2 company name variants from customs records. For current shipment-level data, contact TransData Nexus.